ONB
TEVA icon

Old National Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History

Old National Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
6,929
-109
-2% -$3.63K ﹤0.01% 555
2026
Q1 		$212K Sell
7,038
-115
-2% -$3.7K ﹤0.01% 579
2025
Q4 		$223K Buy
+7,153
New +$176K ﹤0.01% 548
2019
Q2 		– Sell
-10,598
Closed -$166K – 588
2019
Q1 		$166K Hold
10,598
– – 0.01% 547
2018
Q4 		$163K Sell
10,598
-200
-2% -$4.1K 0.01% 544
2018
Q3 		$233K Sell
10,798
-284
-3% -$6.59K 0.01% 564
2018
Q2 		$270K Sell
11,082
-108
-1% -$2.2K 0.01% 522
2018
Q1 		$192K Sell
11,190
-1,334
-11% -$26K 0.01% 592
2017
Q4 		$238K Sell
12,524
-146
-1% -$2.2K 0.01% 563
2017
Q3 		$223K Buy
12,670
+2,773
+28% +$62.4K 0.01% 583
2017
Q2 		$329K Buy
+9,897
New +$306K 0.02% 459
2016
Q4 		– Sell
-8,781
Closed -$404K – 645
2016
Q3 		$404K Sell
8,781
-1,671
-16% -$87.2K 0.02% 410
2016
Q2 		$525K Sell
10,452
-2,317
-18% -$123K 0.03% 324
2016
Q1 		$683K Buy
12,769
+2,835
+29% +$166K 0.04% 287
2015
Q4 		$653K Buy
9,934
+552
+6% +$34.1K 0.04% 280
2015
Q3 		$529K Sell
9,382
-3,086
-25% -$200K 0.03% 319
2015
Q2 		$737K Buy
12,468
+32
+0.3% +$1.97K 0.04% 270
2015
Q1 		$775K Sell
12,436
-6
-0% -$349 0.04% 268
2014
Q4 		$715K Buy
12,442
+602
+5% +$33.5K 0.05% 246
2014
Q3 		$636K Buy
11,840
+6,129
+107% +$325K 0.04% 264
2014
Q2 		$299K Buy
+5,711
New +$292K 0.02% 427
2013
Q4 		– Sell
-8,615
Closed -$326K – 364
2013
Q3 		$326K Buy
8,615
+321
+4% +$12.5K 0.03% 217
2013
Q2 		$325K Buy
+8,294
New +$323K 0.03% 201

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Old National Bancorp's TEVA Position: Q2 2026 in Review

Old National Bancorp reduced its Teva Pharmaceuticals (TEVA) stake by 1.5% in Q2 2026, selling an estimated $3.63K and leaving 6,929 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Old National Bancorp first reported a position in TEVA in Q2 2013 and has held it in 23 quarters since. The position peaked at $775K in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Old National Bancorp held 6,929 shares of Teva Pharmaceuticals worth $235K as of Q2 2026.
  • Old National Bancorp sold 109 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.63K.
  • Teva Pharmaceuticals made up ﹤0.01% of Old National Bancorp's portfolio in Q2 2026, its #555 holding.
  • Old National Bancorp first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • Old National Bancorp's Teva Pharmaceuticals position peaked at $775K in Q1 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.